AzTrials
AzTrials

DermatitisNCT06835192

Impact of Combining Incontinence-associated Dermatitis Prevention and Management Course and Directive Wheel Chart

A study testing Experimental group in people with Dermatitis and Knowledge, Attitudes, Practice, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Background: Knowledge, attitudes, and behaviors regarding the prevention and care of incontinence-associated dermatitis (IAD) need to be enhanced through educational training. There is a lack of innovative courses and convenient tools to assist nursing staff in learning and teaching in clinical settings. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Dermatitis, Knowledge, Attitudes, Practice
What is being tested?
Experimental group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
1 siteTaiwan
Study dates
1 Mar 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • (1)Nurses in the eight adult wards.

Who cannot join

  • New nurses had not completed the three-month probation period;
  • Nurses are holding administrative management positions
  • Nurse practitioners;
  • Nurses who expected to be employed within six months due to job transitions.

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University

    Kaohsiung City, 801

Other trials in Taiwan

About this study

Official title: Impact of Combining Course on Incontinence-associated Dermatitis Prevention and Management with Directive Wheel Chart for Nurses in Adult Wards

Background: Knowledge, attitudes, and behaviors regarding the prevention and care of incontinence-associated dermatitis (IAD) need to be enhanced through educational training. There is a lack of innovative courses and convenient tools to assist nursing staff in learning and teaching in clinical settings.

Purpose: This study aims to investigate the learning outcomes of nursing staff in adult wards regarding the prevention and care of IAD, comparing the effectiveness of a course combined with an Directive Wheel Chart versus a course alone. Additionally, the study examines the effectiveness of nursing staff applying the course and Directive Wheel Chart in peer teaching.

Read the detailed description

Design: This study was a two-phase randomized controlled trial conducted at a regional teaching hospital in Taiwan.

Materials and Methods: The study involved eight wards, comprising a total of 106 nurses, who were initially randomly assigned to either an experimental group (EG) or a control group (CG). Subsequently, the nurses within each ward were randomly allocated to two phases. The researcher delivered a 50-minute lecture to both groups, providing the IAD directive wheel chart only to the nurses in the EG. After a two-weeks period, one or two nurses from each ward in the first phase utilized the same course and directive wheel chart to peer-teach the nurses in the second phase within the same wards. The Chinese version of the Knowledge, Attitudes and Practices of Incontinence-associated Dermatitis Questionnaire (KAP-IAD-Q-C) and the Chinese version of the attitude towards the prevention of incontinence-associated dermatitis instrument (APrIAD-C) were employed to evaluate effectiveness. The Generalized Estimating Equation (GEE) was utilized to analyze the effectiveness of the educational intervention for each phase.

Being tested
Experimental group, Control Group
Keywords
Attitude, Course, Directive wheel chart, Incontinence-associated dermatitis, Knowledge, Practice
Medical subject headings
Dermatitis, Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Experimental groupOther

    Also called Combining Incontinence-associated Dermatitis Prevention and Management Course and Directive Wheel Chart

    Initially, the first author presented a 25-minute lecture with a PowerPoint presentation to the nurses of the EG. Following this, each nurse received an IAD directive wheel chart. In the subsequent 25 minutes, the first author presented three clinical cases examples and relevant information, encouraging the nurses to utilize the IAD directive wheel chart in groups. To conclude the session, a 5-minute quiz was conducted, featuring five actual clinical photographs. After the course, the nurses were instructed to take the IAD directive wheel chart back to their clinics for review and use in health education and teaching.

  • Control GroupOther

    Also called Incontinence-associated Dermatitis Prevention and Management Course

    The first author conducted a 25-minute knowledge lecture for the nurses in the CG on the same topics covered in the EG. This lecture included an explanation of IAD, its causes, the latest global classification of IAD, as well as methods for skin prevention and IAD care. Following the lecture, the same three clinical examples presented in the EG were discussed for an additional 20 minutes, during which the nurses were divided into groups for case discussions. Finally, a 5-minute quiz competition was held, featuring the same five actual clinical photographs used in the EG.

Study groups in NCT06835192
Study groupRoleWhat they receive
Experimental groupExperimentalCombining Incontinence-associated Dermatitis Prevention and Management Course and Directive Wheel Chart
Receives: Other: Experimental group; Other: Control Group
Control GroupOtherThe first author conducted a 25-minute knowledge lecture for the nurses in the CG on the same topics covered in the EG. This lecture included an explanation of IAD, its causes, the latest global classification of IAD, as well as methods for skin prevention and IAD care. Following the lecture, the same three clinical examples presented in the EG were discussed for an additional 20 minutes, during which the nurses were divided into groups for case discussions. Finally, a 5-minute quiz competition was held, featuring the same five actual clinical photographs used in the EG.
Receives: Other: Experimental group; Other: Control Group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The incontinence associated dermatitis knowledge, attitude and practice questionnaire (KAP-IAD-Q)

    The total score ranges from 22 to 110 with higher scores indicating better the knowledge, attitude, and practical behaviors concerning IAD.

    Measured: Four weeks prior to the course, after the teaching courses, four weeks after the course

  2. The attitude towards the prevention of incontinence-associated dermatitis instrument (APrIAD)

    The questionnaire consists of 14 questions, each scored on a 4-point Likert scale., with a total score ranging from 0 to 42.

    Measured: Four weeks prior to the course, after the teaching courses, four weeks after the course

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Feb 2025
  2. Study start1 Mar 2024
  3. Primary completion31 Dec 2024
  4. Study completion31 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
pretest-posttest design
Masking
None (open label)
Enrolment
144 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06835192
Sponsor's protocol ID
KMUHIRB-E(I)-20240128
Status last verified
Oct 2024
First submitted
18 Dec 2024
Last updated
19 Feb 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Experimental group in people with Dermatitis and Knowledge, Attitudes, Practice, run by Kaohsiung Medical University Chung-Ho Memorial Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The incontinence associated dermatitis knowledge, attitude and practice questionnaire (KAP-IAD-Q) (time frame: Four weeks prior to the course, after the teaching courses, four weeks after the course). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Feb 2025; AzTrials last refreshed its copy on 7 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in